Takeda acquisition
October 13, 2011
JAPANESE pharmaceutical
company Takeda has acquired the
Swiss pharmaceutical business,
Nycomed for €9.6 billion, naming
Frank Morich as CEO of the Zurichbased
Nycomed.
The acquisition, according to
Morich will bring “enhanced
revenue, growth and diversification,
while maintaining the strong
momentum of both companies”.
Heading up the combined Takeda
and Nycomed commercial
operation in Australia is the newly
appointed Commercial Country
Leader, James Jones.
“Takeda is now the 12th largest
pharmaceutical company in the
world, with a combined presence in
more than 70 countries,” said Jones.
“The integration unites the best
talents from both companies,
creating an unbeatable workforce
and vibrant global culture,” he added.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Oct 11To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Oct 11